Uncovering Vaccine Adjuvants from Toll-like Receptor 4 Agonist

被引：0
|
作者：
Romaine, Marian [1 ]
机构：
[1] CUNY Hunter Coll, New York, NY USA
来源：
JOURNAL OF BIOLOGICAL CHEMISTRY | 2024年 / 300卷 / 03期
基金：
美国国家卫生研究院;
关键词：
Toll-like Receptor 4; Anti-inflammatory; phytochemical; vaccine adjuvants; Lipopolysaccharide;
D O I：
10.1016/j.jbc.2024.106024
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
2030
引用
收藏
页码：S144 / S144
页数：1
相关论文
共 50 条
  • [41] Salivary and Plasma Levels of Toll-Like Receptor 2 and Toll-Like Receptor 4 in Chronic Periodontitis
    Buduneli, Nurcan
    Ozcaka, Ozgun
    Nalbantsoy, Ayse
    JOURNAL OF PERIODONTOLOGY, 2011, 82 (06) : 878 - 884
  • [42] Comparative fine maps of bovine toll-like receptor 4 and toll-like receptor 2 regions
    Stephen N. White
    Srinivas R. Kata
    James E. Womack
    Mammalian Genome, 2003, 14 : 149 - 155
  • [43] A Partial Toll-like Receptor 4 Agonist Attenuates Pain While Maintaining Immunosufficiency
    Traub, Richard J.
    Melemedjian, Ohannes
    Hanson, Shelby
    Ernst, Robert K.
    Scott, Alison J.
    JOURNAL OF PAIN, 2024, 25 (04): : 7 - 7
  • [44] The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer
    Vindevogel, Eva
    Baert, Thais
    Van Hoylandt, Anais
    Verbist, Godelieve
    Vande Velde, Greetje
    Garg, Abhishek D.
    Agostinis, Patricia
    Vergote, Ignace
    Coosemans, An
    ANTICANCER RESEARCH, 2016, 36 (11) : 5781 - 5792
  • [45] Comparative fine maps of bovine toll-like receptor 4 and toll-like receptor 2 regions
    White, SN
    Kata, SR
    Womack, JE
    MAMMALIAN GENOME, 2003, 14 (02) : 149 - 155
  • [46] The Toll-Like Receptor Agonist Imiquimod Is Active against Prions
    Oumata, Nassima
    Phu Hai Nguyen
    Beringue, Vincent
    Soubigou, Flavie
    Pang, Yanhong
    Desban, Nathalie
    Massacrier, Catherine
    Morel, Yannis
    Paturel, Carine
    Contesse, Marie-Astrid
    Bouaziz, Serge
    Sanyal, Suparna
    Galons, Herve
    Blondel, Marc
    Voisset, Cecile
    PLOS ONE, 2013, 8 (08):
  • [47] Selective TRIF-Dependent Signaling by a Synthetic Toll-Like Receptor 4 Agonist
    Bowen, William S.
    Minns, Laurie A.
    Johnson, David A.
    Mitchell, Thomas C.
    Hutton, Melinda M.
    Evans, Jay T.
    SCIENCE SIGNALING, 2012, 5 (211)
  • [48] Peptide vaccine given with a Toll-like receptor agonist is effective for the treatment and prevention of spontaneous breast tumors
    Nava-Parada, Pilar
    Forni, Guido
    Knutson, Keith L.
    Pease, Larry R.
    Celis, Esteban
    CANCER RESEARCH, 2007, 67 (03) : 1326 - 1334
  • [49] Toll-like Receptor 4 and Hepatic Fibrogenesis
    Pradere, Jean-Philippe
    Troeger, Juliane S.
    Dapito, Dianne H.
    Mencin, Ali A.
    Schwabe, Robert F.
    SEMINARS IN LIVER DISEASE, 2010, 30 (03) : 232 - 244
  • [50] Toll-like receptor 4 in CNS pathologies
    Buchanan, Madison M.
    Hutchinson, Mark
    Watkins, Linda R.
    Yin, Hang
    JOURNAL OF NEUROCHEMISTRY, 2010, 114 (01) : 13 - 27
12345